Skip to main content
. 2016 Jan 8;14:6. doi: 10.1186/s12967-015-0752-1

Fig. 1.

Fig. 1

Study workflow indicating cold ischemia time points, quality control of samples, and subsequent proteomic analysis. Patient samples were collected at time point 0 and subjected to cold ischemia. Subsequently, the tumor content of samples was adjusted to ≥50 % and protein lysates were prepared for further proteomic analysis